101 related articles for article (PubMed ID: 3862426)
1. Myometrial activity in first trimester human pregnancy after Epostane therapy. Effect of intravenous oxytocin.
Webster MA; Pattison NS; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):957-62. PubMed ID: 3862426
[TBL] [Abstract][Full Text] [Related]
2. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.
Webster MA; Phipps SL; Gillmer MD
Br J Obstet Gynaecol; 1985 Sep; 92(9):963-8. PubMed ID: 3862427
[TBL] [Abstract][Full Text] [Related]
3. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
[TBL] [Abstract][Full Text] [Related]
4. Induction of abortion in early first trimester human pregnancy using epostane.
Webster MA; Gillmer MD
Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane.
Pattison NS; Webster MA; Phipps SL; Anderson AB; Gillmer MD
Fertil Steril; 1984 Dec; 42(6):875-81. PubMed ID: 6437877
[TBL] [Abstract][Full Text] [Related]
6. Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.
Crooij MJ; de Nooyer CC; Rao BR; Berends GT; Gooren LJ; Janssens J
N Engl J Med; 1988 Sep; 319(13):813-7. PubMed ID: 3166108
[TBL] [Abstract][Full Text] [Related]
7. Effects on maternal and fetal steroid concentrations of induction of parturition in the sheep by inhibition of 3 beta-hydroxysteroid dehydrogenase.
Silver M
J Reprod Fertil; 1988 Mar; 82(2):457-65. PubMed ID: 2834551
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhibition of prostaglandin synthesis on cervical softening and uterine activity during ovine parturition resulting from progesterone withdrawal induced by epostane.
Ledger WL; Webster MA; Anderson AB; Turnbull AC
J Endocrinol; 1985 May; 105(2):227-33. PubMed ID: 3857291
[TBL] [Abstract][Full Text] [Related]
9. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
Birgerson L; Odlind V
Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhibiting 3 beta-hydroxysteroid dehydrogenase on plasma progesterone and other steroids in the pregnant mare near term.
Fowden AL; Silver M
J Reprod Fertil Suppl; 1987; 35():539-45. PubMed ID: 3479607
[TBL] [Abstract][Full Text] [Related]
11. The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation.
Selinger M; MacKenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1988 Jun; 95(6):596-601. PubMed ID: 3291938
[TBL] [Abstract][Full Text] [Related]
12. Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep.
Ashworth CJ; Wilmut I; Springbett AJ; Webb R
J Endocrinol; 1987 Feb; 112(2):205-13. PubMed ID: 3469294
[TBL] [Abstract][Full Text] [Related]
13. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery.
Chwalisz K
Hum Reprod; 1994 Jun; 9 Suppl 1():131-61. PubMed ID: 7962460
[TBL] [Abstract][Full Text] [Related]
14. Hormonal factors in the regulation of myometrial activity. An in vivo study.
Laudański T
Acta Obstet Gynecol Scand Suppl; 1979; 91():1-32. PubMed ID: 294804
[No Abstract] [Full Text] [Related]
15. Induction of parturition in swine and epostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase.
Martin PA; Hammitt DG; Strohbehn RS; Keister DM
J Anim Sci; 1987 Feb; 64(2):497-506. PubMed ID: 3470276
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions.
Fuchs AR; Rasmussen AB; Rehnström J; Toth M
Am J Obstet Gynecol; 1984 Sep; 150(1):27-32. PubMed ID: 6476024
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 3 beta-hydroxysteroid dehydrogenase in the sow near term: effects on fetal and maternal steroids and on delivery.
Silver M; Fowden AL
Q J Exp Physiol; 1988 Jan; 73(1):67-78. PubMed ID: 3162325
[TBL] [Abstract][Full Text] [Related]
18. Effects of epostane on ovarian levels of progesterone, 17 beta-estradiol, prostaglandin E2, and prostaglandin F2 alpha during ovulation in the gonadotropin-primed immature rat.
Espey LL; Adams RF; Tanaka N; Okamura H
Endocrinology; 1990 Jul; 127(1):259-63. PubMed ID: 2361472
[TBL] [Abstract][Full Text] [Related]
19. Potentiating effect of epostane on pregnancy terminating activity of RU 486 in the rat.
Vanage G; Kadam PA; Bardin CW; Koide SS
Contraception; 1993 May; 47(5):499-506. PubMed ID: 8513677
[TBL] [Abstract][Full Text] [Related]
20. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys.
Haluska GJ; Cook MJ; Novy MJ
Am J Obstet Gynecol; 1997 Mar; 176(3):682-91. PubMed ID: 9077629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
